“The international Growth Hormone Deficiency Market research report provides extensive analysis of the market structure as well as estimates of various market segments and sub-segments. If the reports are accompanied by the right tools and technology, they also help overcome uncertain challenges for businesses. The report is based on market type, organization size, local availability, end-user organization type, and availability in regions such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. A superior Growth Hormone Deficiency Market Report also highlights various product market barriers and drivers both quantitatively and qualitatively so that users get the right information.
To achieve tremendous business growth, Growth Hormone Deficiency Market research reports play a very important role. This worldwide report helps to know how the market will perform in the forecast years by providing information on definition, classification, application, and involvement of the market. Moreover, market share analysis as well as key trends analysis are the major determining factors in this market report. Furthermore, this business report provides a detailed explanation of the market analysis with inputs from industry experts. By truly understanding the client’s requirements completely and following them strictly, the Growth Hormone Deficiency Market research report has been prepared.
The expected CAGR of growth hormone deficiency treatment market is tend to be around 5.2% in the mentioned forecast period. The market was valued at USD 4187.2 million in 2022, and it would grow upto USD 6281.30 million by 2030.
Explore Further Details about This Research Growth Hormone Deficiency Market Report https://www.databridgemarketresearch.com/reports/global-growth-hormone-deficiency-market
Growth Hormone Deficiency Treatment Market Scope and Segmentation
|
REPORT METRIC |
DETAILS |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 – 2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency), Route of Administration (Intravenous, Intramuscular, Others), Treatment (Pharmacological Therapy, Recombinant Human Growth Hormone, Human Pituitary Gland Extracts, Surgery), Diagnosis (Blood Tests, Imaging Tests, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Zydus Group (India), AstraZeneca (U.K.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Lilly (U.S.), Cipla Inc. (U.S.), Ipsen Pharma (France), Novo Nordisk A/S (Denmark), Abbott (U.S.), Abbvie, Inc (U.S.) |
|
Market Opportunities |
|
Market Definition
Growth hormone deficiency (GHD), also called dwarfism or pituitary dwarfism, is a type of disorder that is caused by a lack of growth hormone in the body. Children with GHD have normal body proportions but are drastically short in stature. It can be congenital or develop over time. If the pituitary gland produces insufficient growth hormone, this disease occurs. Genetic problems, a serious brain injury, or being born without a pituitary gland, can cause it.
Growth Hormone Deficiency Treatment Market Dynamics
Drivers
- Increasing Trend of urban lifestyle
Urban lifestyles and declining food habits are expected to rise the demand for human growth hormone drugs and varied treatment facilities. There has been a rise in stress and sleeplessness due to the hectic life patterns of the citizens working in cities. This is leading to huge hormonal imbalance in the body. Thus, this factor leads to the deficiency in people.
- Increase in Growth Deficiencies
There has been a persistent increase in public understanding associated with the use of synthetic growth hormone therapy. The increasing industrial research for the causes of growth deficiencies, along with an improving occurrence of diagnosis, caused an increase in market growth. Numerous growth-related issues such as adult growth hormone deficiency, idiopathic low stature, pediatric growth hormone deficit, and hereditary illnesses such as Turner syndrome and Prader-Willi syndrome are causing enough to boost the market size. Worldwide, 1 in 3800 children suffers from a growth hormone deficit. Turner syndrome affects around 1 in every 2000 females, and Prader-Willi syndrome affects 1 in every 30,000 persons. Thus, it boosts the market growth.
Opportunities
- Increased Elderly Population
The increasing elderly population is projected to increase the market’s expansion during the forecast period of 2023-2030. As per the World Health Organization, the worldwide elderly population, which was projected to be more than 524 million in 2010, is predicted to increase to almost 2 billion by 2050. Elderly people are more vulnerable to growth diseases because of their compromised immune systems, further estimated to enhance the market’s growth rate.
- Rising Government Initiatives
The numerous initiatives taken by many government and private organizations to spread awareness about growth hormone deficiencies and human growth hormone treatment are expected to drive the market.
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2022)
- Past Pricing and price curve by region (2018 to 2022)
- Market Size, Share, Size & Forecast by different segment | 2023−2029
- Growth Hormone Deficiency Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of Business by Region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Browse Related Reports:
Immunohematology Market Size, Share & Trends [Report]
Cell Permeabilization Market Share Statistics Report,Size, Forecast, & Trends
Solid Masterbatches Market Size, Global Industry Share, Recent
Epoxides Market by Size, Share, Forecasts, & Trends
Orbital Atherectomy Market Size | Statistics Report, Share, Forecast, & Trends
Ophthalmology Electronic Health Record (EHR) Market Size, Share & Trends Analysis Report
Isothermal Nucleic Acid Amplification Tests Market Size and Forecasts, Share and Trends
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
“
